References
- Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90(1)195–203
- Davis M, Espiner E, Richards G, Billings J, Town I, Neill A, et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 1994; 343(8895)440–4
- Hess G, Runkel S, Zdunek D, Hitzler WE. Reference interval determination for N-terminal-B-type natriuretic peptide (NT-proBNP): a study in blood donors. Clin Chim Acta 2005; 360(1–2)187–93
- Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998; 339(5)321–8
- Mueller C, Breidthardt T, Laule-Kilian K, Christ M, Perruchoud AP. The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly 2007; 137(1–2)4–12
- Tihtonen KM, Koobi T, Vuolteenaho O, Huhtala HS, Uotila JT. Natriuretic peptides and hemodynamics in preeclampsia. Am J Obstet Gynecol. 2007; 196(4)328 e1–7
- Pruszcyk P. N-terminal pro-brain natriuretic peptide as an indicator of right ventricular dysfunction. J Card Fail. 2005; 11(5 Suppl)65–9
- Itoh H, Sagawa N, Nanno H, Mori T, Mukoyama M, Itoh H, et al. Impaired guanosine 3′,5′-cyclic phosphate production in severe pregnancy-induced hypertension with high plasma levels of atrial and brain natriuretic peptides. Endocr J. 1997; 44(3)389–93
- Okuno S, Hamada H, Yasuoka M, Watanabe H, Fujiki Y, Yamada N, et al. Brain natriuretic peptide (BNP) and cyclic guanosine monophosphate (cGMP) levels in normal pregnancy and preeclampsia. J Obstet Gynaecol Res. 1999; 25(6)407–10
- Resnik JL, Hong C, Resnik R, Kazanegra R, Beede J, Bhalla V, et al. Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women. Am J Obstet Gynecol. 2005; 193(2)450–4
- Yoshimura T, Yoshimura M, Yasue H, Ito M, Okamura H, Mukoyama M, et al. Plasma concentration of atrial natriuretic peptide and brain natriuretic peptide during normal human pregnancy and the postpartum period. J Endocrinol. 1994; 140(3)393–7
- Kale A, Kale E, Yalinkaya A, Akdeniz N, Canoruc N. The comparison of amino-terminal probrain natriuretic peptide levels in preeclampsia and normotensive pregnancy. J Perinat Med. 2005; 33(2)121–4
- Lev-Sagie A, Bar-Oz B, Salpeter L, Hochner-Celnikier D, Arad I, Nir A. Plasma concentrations of N-terminal Pro-B-Type natriuretic peptide in pregnant women near labor and during early puerperium. Clin Chem. 2005; 51(10)1909–10
- Bosio PM, McKenna PJ, Conroy R, O'Herlihy C. Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol. 1999; 94(6)978–84
- Chapman AB, Abraham WT, Zamudio S, Coffin C, Merouani A, Young D, et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int. 1998; 54(6)2056–63
- Franz MB, Guenthner-Biller MM, Kainer F, Schiessl B. Pro-B-type natriuretic peptide as a marker of pulmonary embolism in pregnancy: a case report. Arch Gynecol Obstet. 2008; 277(5)439–40